Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Nanoparticles transfected with plasmid-encoded lncRNA-OIP5-AS1 inhibit renal ischemia-reperfusion injury in mice via the miR-410-3p/Nrf2 axis
Injectable delivery achieves tissue concentrations 10-20 times higher than topical application
It accelerates blood vessel formation (angiogenesis), modulates inflammatory pathways, and enhances collagen synthesis, all of which are crucial for tissue recovery
SARS-CoV-2 new therapeutic approaches The prominence of the coronavirus disease 2019 (COVID-19) pandemic urges multidisciplinary strategies to control disease spread and prevent its complications (Labarrere and Kassab, 2021)
The evidence pattern from user experiences places acute soft tissue injuries at the top of the response hierarchy (60 to 70% report clear benefit), followed by muscle strains, gastrointestinal issues, and post-surgical recovery
US$ 20.40
US$ 27.77
US$ 21.34
US$ 27.86
US$ 20.01
US$ 23.37
US$ 27.46
US$ 28.01
